We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+1.13%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$2.46B
AUM Growth
+$238M
Cap. Flow
+$217M
Cap. Flow %
8.81%
Top 10 Hldgs %
17.01%
Holding
976
New
195
Increased
478
Reduced
214
Closed
88

Top Buys

Rank Stock Value
1
CGNX icon
Cognex
CGNX
+$18.8M
2
ROK icon
Rockwell Automation
ROK
+$14.2M
3
IRBT
iRobot
IRBT
+$14.1M
4
OII icon
Oceaneering
OII
+$13.8M
5
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$11.2M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$59.4M
2
RAVN
Raven Industries Inc
RAVN
+$11.9M
3
ETG
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
+$10.7M
4
CSQ icon
Calamos Strategic Total Return Fund
CSQ
+$10.2M
5
CHI
Calamos Convertible Opportunities and Income Fund
CHI
+$9.51M

Sector Composition

Rank Sector Weight
1 Technology 28.44%
2 Industrials 13.87%
3 Healthcare 11.83%
4 Consumer Discretionary 8.52%
5 Financials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALV icon
326
Autoliv
ALV
$9B
$1.77M 0.07%
+16,237
New +$1.67M
NFLX icon
327
Netflix
NFLX
$309B
$1.76M 0.07%
57,040
-27,700
-33% -$754K
DVAX
328
DELISTED
Dynavax Technologies
DVAX
$1.75M 0.07%
91,414
+25,176
+38% +$435K
EVT icon
329
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.16B
$1.75M 0.07%
+77,960
New +$1.78M
TCRT icon
330
Alaunos Therapeutics
TCRT
$4.86M
$1.74M 0.07%
2,667
+713
+36% +$444K
NVS icon
331
Novartis
NVS
$297B
$1.7M 0.07%
23,326
+6,830
+41% +$520K
KDNY
332
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.7M 0.07%
42,329
+11,501
+37% +$421K
BLUE
333
DELISTED
bluebird bio
BLUE
$1.69M 0.07%
761
+283
+59% +$720K
PG icon
334
Procter & Gamble
PG
$339B
$1.65M 0.07%
20,982
– –
TSEM icon
335
Tower Semiconductor
TSEM
$28.5B
$1.64M 0.07%
+57,278
New +$1.82M
ACGN
336
DELISTED
Aceragen Inc
ACGN
$1.58M 0.06%
6,471
+1,758
+37% +$482K
WYNN icon
337
Wynn Resorts
WYNN
$10.6B
$1.58M 0.06%
8,373
+3,354
+67% +$580K
NEE icon
338
NextEra Energy
NEE
$177B
$1.53M 0.06%
37,672
+5,448
+17% +$210K
OGE icon
339
OGE Energy
OGE
$9.71B
$1.49M 0.06%
46,217
+13,084
+39% +$413K
BG icon
340
Bunge Global
BG
$20.8B
$1.49M 0.06%
19,777
-29,816
-60% -$2.25M
TECH icon
341
Bio-Techne
TECH
$11.3B
$1.48M 0.06%
39,620
+10,680
+37% +$377K
FDS icon
342
Factset
FDS
$10.2B
$1.47M 0.06%
7,467
+2,140
+40% +$432K
INCY icon
343
Incyte
INCY
$24.4B
$1.47M 0.06%
20,821
+2,864
+16% +$258K
IBRX icon
344
ImmunityBio
IBRX
$8.1B
$1.45M 0.06%
359,420
+97,406
+37% +$427K
KO icon
345
Coca-Cola
KO
$375B
$1.44M 0.06%
32,148
-5,904
-16% -$265K
CLX icon
346
Clorox
CLX
$12.7B
$1.42M 0.06%
11,201
+312
+3% +$41.9K
IBM icon
347
IBM
IBM
$224B
$1.41M 0.06%
9,363
-483
-5% -$73.1K
HUN icon
348
Huntsman Corp
HUN
$1.77B
$1.41M 0.06%
+45,915
New +$1.5M
FPRX
349
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.41M 0.06%
81,546
+21,779
+36% +$425K
PEP icon
350
PepsiCo
PEP
$190B
$1.38M 0.06%
12,550
-106
-0.8% -$12.1K
12 13
14
15 16

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q1 2018 Portfolio in Review

As of Q1 2018, Vident Investment Advisory held 976 positions worth $2.46B, up 11% from $2.22B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Vident Investment Advisory deployed $217M of net new capital in Q1 2018, opening 195 new positions and adding to 478 existing holdings. Its largest new stake was NexPoint Diversified Real Estate Trust: 340,420 shares worth $7.83M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $59.4M trimmed.

  • Vident Investment Advisory's largest Q1 2018 buy was NexPoint Diversified Real Estate Trust: 340,420 shares worth $7.83M.
  • Vident Investment Advisory added most to Cognex in Q1 2018, an estimated $18.8M increase.
  • Vident Investment Advisory's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $59.4M.
  • Vident Investment Advisory fully exited Eaton Vance Tax-Advantaged Global Dividend Income Fund in Q1 2018, selling an estimated $10.7M.
  • Vident Investment Advisory's ten largest holdings make up 17% of its $2.46B portfolio in Q1 2018.
  • Vident Investment Advisory opened 195 new positions and closed 88 in Q1 2018.
  • Vident Investment Advisory's portfolio value rose 11% quarter-over-quarter to $2.46B.

Based on Vident Investment Advisory's 13F filing for Q1 2018, filed 14 May 2018.